Found 10 matching trials
Efficacy and Safety of Masitinib in Combination With SoC Versus Placebo in the Treatment of ALS Patients
PHASE3The objective is to compare the efficacy and safety of masitinib in combina...
Location
Aiginition Hospital
Masitinib in Patients With Symptomatic Mild to Moderate COVID-19
PHASE2The objective of the study is to evaluate the anti-viral efficacy of 3 diff...
Location
Intensive Care Unit, CHU Gabriel-Montpied
Masitinib in Combination With Riluzole for the Treatment of Patients Suffering From Amyotrophic Lateral Sclerosis (ALS)
PHASE2The objective is to compare the efficacy and safety of masitinib in combina...
Location
Hospital Carlos III
Masitinib in Patients With Mild to Moderate Alzheimer's Disease
PHASE3The purpose of this study is to assess the safety and efficacy of masitinib...
Location
MHAT Sveta Marina
Masitinib in the Treatment of Patients With Primary Progressive or Non-active Secondary Progressive Multiple Sclerosis
PHASE3To evaluate the efficacy and safety of oral masitinib versus placebo in the...
Location
Service de Neurologie Hôpital Henri-Mondor
Masitinib in the Treatment of Patients With Severe Uncontrolled Asthma and Elevated Eosinophil Levels
PHASE3The purpose of this study is to assess the safety and efficacy of masitinib...
Location
Centro Respiratorio Quilmes
Masitinib in Patients With Mild Alzheimer's Disease
PHASE3Masitinib is an orally administered tyrosine kinase inhibitor that targets ...
Location
Institut de la mémoire et Maladie d'Alzheimer, Hôpitaux Universitaires Pitié-Salpêtrière
Efficacy and Safety of Masitinib Versus Placebo in the Treatment of ALS Patients
PHASE3The objective is to compare the efficacy and safety of masitinib in combina...
Location
University of Alabama at Birmingham
Masitinib in Severe Indolent or Smoldering Systemic Mastocytosis Unresponsive to Optimal Symptomatic Treatment
PHASE3The purpose of this study is to evaluate the efficacy and safety of oral ma...
Location
Centre Hospitalier Universitaire d'Amiens
Masitinib for the Treatment of Severe Mast Cell Activation Syndrome
PHASE2To evaluate the efficacy and safety of two dosing schemes of oral masitinib...
Location
St Charles Clinical Research